evalu long term tobramycin therapi patient cystic fibrosi advanc pulmonari diseas nine cystic fibrosi patient chronic bronchopulmonari infect sever damag lung invad pseudomona aeruginosa eleven cours prolong tobramycin treatment 5 mgkgday four 16 week administ pulmonari symptom improv better qualiti life wa achiev one patient object paramet chest xray pulmonari function test chang lesser extent onli one patient wa pseudomona erad sputum reappear discontinu therapi rest patient pseudomona wa significantli suppress replac pathogen four patient show rise antibodi titr candida two aspergillu fumigatu nephrotox side effect observ vestibular function wa revers impair one patient without correspond clinic symptom bacteri resist tobramycin wa observ dure therapi